Med mindre losartanbehandling anses for essentiel, bør patienter, der planlægger graviditet, skiftes til alternativ antihypertensiv behandling, som har en etableret sikkerhedsprofil for anvendelse under graviditet.
Unless continued losartan therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.